The Clarify Consortium is a partnership of 12 institutions from five different countries (Spain, Germany, Portugal, Ireland and United Kingdom) working together throughout the project framework. The consortium participating in CLARIFY has been selected in order to complete the required capacities and to cover all the expertise fields that will be faced by the project, thus ensuring the scientific excellence and the fulfilment of the objectives initially planned.
The Consortium members have differential but complementary skills and abilities. Each participant is a specialist in its specific field, but requires the expertise of complementary partners in areas such as project management, technology transfer, dissemination, or entrepreneurship, to name a few.
CLARIFY comprises seven renowned research institutions, three industrial partners, and two Scientific Associations. All and each one of these partners provide a valuable Know-How to the consortium.
RTD partners combine different knowledge and expertise in Big Data Processing, Natural language, Data Analytics, and Machine Learning. Two scientific associations of oncology specialists are also involved in the consortium; they will be working in close cooperation with the project coordinator, Hospital Universitario Puerta de Hierro-Majadahonda, which will provide the cancer patients to the project from their Medical Oncology Department, and further provide the relevant clinical variables. The academic / research partners will play the main role of the project, and the participation of a large industry firm like ACC and two more high-tech companies (STELAR and HOLOS) will ensure a strong exploitation of the project results in the industry and commercial benefits from the project.